Global Cardiovascular Strategies

---

CARDIOVASCULAR DISEASE PANDEMICS:
THE GLOBAL VIEW ON MORTALITY AND RISK FACTORS
E Farinaro, S Stranges, E Della Valle, G Guglielmucci, A Cajafa, M Triassi and A Chockalingam

---

 

REFERENCES

1) Labarthe DR. Epidemiology and Prevention of Cardiovascular Disease. A Global Challenge. Gaithersburg, Maryland, USA: an Aspen Publication, 1998.

2) Murray ChJL, Lopez AD. The Global Burden of Disease. A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Harvard School of Public Health on behalf of the WHO and the World Bank, 1996.

3) 1990-1995 World Health Statistics Annual. Geneva: WHO, 1991-1996.

4) The World Health Report 1997. Conquering, Suffering, Enriching Humanity. Geneva: World Health Organization, 1997.

5) Pearson TA, Jamison DT, Trejo-Gutierrez H. Cardiovascular disease. In: Jamison DT (Ed.). Disease Control Priorities in Developing Countries. New York: Oxford University Press, 1993: 577-599.

6) Farinaro E (co-author). Impending Global Pandemic of Cardiovascular Diseases. Challenges and opportunities for the prevention and control of cardiovascular diseases in developing countries and economies in transition. Chockalingam A, Balaguer-Vintro I, eds. World Heart Federation, Geneva, Switzerland. Barcelona, Spain: Prous Science, 1999.

7) Omran AR. The epidemiological transition: A key of the epidemiology of population change. Milbank Q 1971; 49: 509-538.

8) International Advisory Board. Victoria Declaration on Heart Health. Health and Welfare Canada, Victoria, Canada, 1992.

9) World Bank. Human Development and Network Strategy. Health, Nutrition and Population Division, World Bank, Washington DC, 1997.

10) Hinkle LE. Ecological observations of the relation of physical illness, mental illness, and the social environment. Psychosomatic Med 1961; 23: 289-296.

11) Hinkle LE, Whitney H, Lehman EW, Dunn J, et al. Occupation, education, and coronary heart disease. Science 1968; 161: 238-246.

12) Olshansky SJ, Ault AB. The fourth stage of the epidemiologic transition: the age of delayed degenerative disease. Milbank Q 1986; 64: 355-391.

13) Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951; 41: 279-286.

14) Kromhout D, Menotti A, Bloemberg B, Aravanis C, et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995; 24: 308-315.

15) The Multiple Risk Factor Intervention Trial Research Group. Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial. Circ 1996; 94: 946-951.

16) Levy D, Wilson PWF, Anderson KM, Castelli WP. Stratifying the patient at risk from coronary heart disease: new insights from the Framingham study. Am Heart J 1990; 119: 712-717.

17) Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile – a statement for health professionals. Circ 1991; 83: 356-362.

18) Farinaro E (coordinator). European Atherosclerosis Society and International Task Force for Prevention of Coronary heart Disease. Prevention of coronary heart disease: scientific background and new clinical guidelines. Nutr Metab Cardiovas Dis 1992; 2: 113-156.

19) Assmann G, Schulte H, Cullen P. New and classical risk factors — the Münster heart study (PROCAM). Eur J Med Res 1997; 6: 237-242.

20) International Task Force for Prevention of Coronary heart Disease. Coronary Heart Disease: Reducing the Risk. The Scientific background for primary and secondary prevention of Coronary Heart disease. Nutr Metab Cardiovasc 1998; 8: 205-271.

21) The INTERSALT Study: background, methods, findings, and implications. Am J Clin Nutr 1997; 65 (suppl): 626S-642S.

22) INTERSALT Cooperative Research Group. INTERSALT: an International Study of electrolyte and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Br Med J 1988; 297: 319-328.

23) Murray, Ch.J.L., Lopez, A.D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-1276.

24) Pan American Health Organization (PAHO) Annual Report, Washington, DC, 1997.

25) Kaplan G.A., Lynch J.W. Socioeconomic Considerations in the Primordial Prevention of Cardiovascular Disease. Preventive Medicine 1999; 29 (6): S30-S35.

26) Doll R. Peto R. Wheatley K., Gray R., et al. Mortality in relation to smoking: 40 years’ observations on male British doctors. Br Med J 1994; 309: 901-911.

27) Stehbens WE. Causality in medical science with particular reference to heart disease and atherosclerosis. Perspect Biol Med 1992; 36: 97-119.

28) Cardiovascular Disease Risk Factors: New Areas for Research. Report of a WHO Scientific group. WHO Technical Report Series No. 841, World Health Organization, Geneva, 1994.

29) Postiglione A, Panico S, Lewis B, Eisenberg S, et al, for the Council on Arteriosclerosis of the International Society and Federation of Cardiology (ISFC). New and candidate risk factors for coronary heart disease. Nutr Metab Cardiovas Dis 1994; 4: 233-256.

30) Diagnosis and management of new cardiovascular risk factors. Eur Heart J 1998; 19 (suppl O): O13-O19.

31) Farinaro E, Motti C, Stranges S, Iacuzio L, De Cicco A, D’Argenzio A, Santoro E, Cortese C. Interaction between genetics and environment in coronary heart disease: the European Atherosclerosis Research Study (EARS). L’Igiene Moderna 1998; 110: 283-313.

32) Theorell T. The psycho-social environment, stress, and coronary heart disease. In: Marmot M, Elliott P, eds. Coronary Heart Disease Epidemiology: from Aetiology to Public Health. Oxford, England: Oxford University Press; 1992: 256-273.

33) Rosenman RH, Brand RJ, Sholtz RI, Friedman M. Multivariate prediction of coronary heart disease during 8.5 year follow-up in the Western Collaborative Group Study. Am J Cardiol 1976; 37: 903-910.

34) Ragland DR, Brand RJ. Type A behaviour and mortality from coronary heart disease. N Engl J Med 1988; 318: 65-69.

35) Carney RM, Freeland KE, Rich MW, Jaffe AS. Depression as a risk factor for cardiac events in established coronary heart disease; a review of possible mechanisms. Ann Behav Med; 17: 142-149.

36) Eriksen W. The role of social support in the pathogenesis of coronary heart disease: a literature review: Fam Prac 1994; 11: 201-209.

37) Levine DM. Behavioural and psycho-social factors, processes and strategies. In Pearson TA, Criqui MH, Luepker RV, Oberman A, Winston M, eds. Primer in Preventive Cardiology. Dallas, Tex: American Heart Association; 1994: 217-226.

38) Kunst AE, Groenhof F, Mackenbach J, European Union Working Group on Socioeconomic Inequalities in Health. Differences between occupational classes in cardiovascular disease mortality: a comparison of 11 European countries. In: Report of the Conference on Socio-economic Status and Cardiovascular Health and Disease, November 6-7, 1995. Bethesda, MD: National Heart, Lung and Blood Institute, National Institutes of Health; 1995: 49-56.

39) Marmot MG, Adelstein AM, Robinson N, Rose GA. Changing social-class distribution of heart disease. Br Med J 1978; 2: 1109-1112.

40) Barker DJP. The origins of coronary heart disease in early life. In: Henry CJK, Ulijaszek SJ, eds. Long-Term Consequences of Early Environment. Cambridge, England: Cambridge University Press; 1966: 155-162.

41) Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav 1995; 36: 80-94.

42) Farinaro E, De Riu G, Stranges S, Guglielmucci G, eds. Proceedings of the International Symposium on Social Inequalities and Health. Ann Ig 2000; 12 (suppl 1): S1-S81.

43) Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J 1981; 282: 1847-1851.

44) Strasser T. Reflections on cardiovascular diseases. Interdisc Sci Rev 1978; 3: 225-230.

45) World Health Organisation Expert Committee. Prevention in Childhood and Youth of Adult Cardiovascular Diseases: Time for Action. Geneva, Switzerland: World Heart Organisation; 1990. WHO Technical Report Series 792.

46) Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14: 32-38.

47) Rose G. The Strategy of Preventive Medicine. Oxford, England: Oxford University Press; 1992.

48) Stamler J. Primary prevention of coronary heart disease: the last 20 years. Am J Cardiol 1981; 47: 722-735.

49) De Rerum Natura – Tito Lucrezio Caro – libro V vv1007-1008.